124
Participants
Start Date
August 31, 2021
Primary Completion Date
June 7, 2024
Study Completion Date
June 7, 2024
Relivion®DP- Active
Relivion®DP- Active stimulation device
Relivion®DP- Sham
Relivion®DP- Sham stimulation device
Sheppard Prat Health system, Baltimore
University of North Carolina, Department of Psychiatry, Chapel Hill
MUSC Institute of Psychiatry, Charleston
San Marcus Research Clinic, Miami Lakes
K2 Medical Research Tampa, Tampa
University of Minnesota, Minneapolis
Northwestern University, Feinberg School of Medicine, Chicago
Brain Health Consultants and TMS Center, Houston
UCLA Semel Institute for Neuroscience and Behaviour, Los Angeles
Kadima Neuropsychiatry Institute, La Jolla
Butler Hospital/Brown University, Providence
VA Providence Healthcare System, Providence
Ichilov Medical Center, Tel Aviv
Lead Sponsor
Neurolief Ltd.
INDUSTRY